Patents by Inventor Anna Wolska

Anna Wolska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240309065
    Abstract: ApoC-II mimetic peptides of 19-35 amino acids including one or two helical domains with one or more covalent linkages joining at least two non-contiguous amino acids of the peptide, wherein at least one of the helical domains is an amphipathic helical domain, are provided. Methods of treating dyslipidemic disorders, such as hypertriglyceridemia or hypercholesterolemia, using the peptides are also provided.
    Type: Application
    Filed: June 22, 2022
    Publication date: September 19, 2024
    Applicant: The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Alan T. Remaley, Denis Sviridov, Mart Reimund, Anna Wolska, Amaury Dasseux
  • Patent number: 11827690
    Abstract: The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: November 28, 2023
    Assignees: Novo Nordisk Inc., United State of America, As Represented by the Secretary, Dept. of Health and Human Services
    Inventors: Alan Thomas Remaley, Soumitra Shanker Ghosh, Madhav N. Devalaraja, Chih-Hung Lo, Denis O. Sviridov, Anna Wolska
  • Publication number: 20210324043
    Abstract: The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.
    Type: Application
    Filed: March 9, 2021
    Publication date: October 21, 2021
    Inventors: Alan Thomas REMALEY, Soumitra Shanker GHOSH, Madhav N. DEVALARAJA, Chih-Hung LO, Denis O. SVIRIDOV, Anna WOLSKA
  • Patent number: 11136372
    Abstract: The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: October 5, 2021
    Assignees: The United States of America, as represented by the Secretary, Dept. of Health & Human Services, Novo Nordisk A/S
    Inventors: Alan Thomas Remaley, Soumitra Shanker Ghosh, Madhav N. Devalaraja, Chih-Hung Lo, Denis O. Sviridov, Anna Wolska
  • Publication number: 20200140522
    Abstract: The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.
    Type: Application
    Filed: January 19, 2018
    Publication date: May 7, 2020
    Inventors: Alan Thomas Remaley, Soumitra Shanker Ghosh, Madhav N. Devalaraja, Chih-Hung Lo, Denis O. Sviridov, Anna Wolska